Laws in place now for more paediatric products, says US Lumpkin
This article was originally published in Clinica
Executive Summary
The development of medical products specifically designed for children continues to be a major talking point in the US. FDA deputy commissioner for international and special programmes, Murray Lumpkin, said on August 7 that “children deserve better” than what they currently have in the way of medical products.